Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ)1990-472XФедеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации458810.18499/1990-472X-2013-0-52-20-25Original ArticlePATHOGENETIC CORRELATION BETWEEN ALZHEIMER'S DISEASE AND AGE-RELATED MACULAR DEGENERATIONErmilovVV V-NesterovaAA A-Volgograd State Medical University1512201352202525042020Copyright © 2013, Научно-медицинский вестник Центрального Черноземья2013studied 336 eyes and brain, taken from 171 corpses selective methods with photometric Primea nozzle FMEL-1A was performed revealing amyloid and its types. The most commonly encountered form of amyloidosis combines local eyes (60.5% of cases). When combined with AMD asthma in women (mean age 77 years) showed amyloid aged 10 years earlier, and 2 times more likely than men (mean age - 72.3 years). The intensity of the luminescence of amyloid deposits in the vessels of the brain was more pronounced than in the choroidal vessels, where in addition to large vessels, often encountered more intense beta-amyloid deposits and intense glow by reaction with amyloid thioflavin T more pronounced. Senile amyloidosis eyes combined with senile cerebral amyloidosis occurs in the eighth decade of life, and their frequency increases with aging.Амилоидозболезнь Альцгеймеравозрастная макулярная дегенерацияхориодея[1. Автандилов Г. Г. Медицинская морфометрия. - М., 1990.][2. Алпатов С.А., Щуко А.Г., Урнева Е.М., Малышев В.В. Возрастная макулярная дегенерация. М.: ГЭОТАР-Медиа, 2010. С. 13, 35-36.][3. Е.А. Егоров, И.А. Романенко. Современные аспекты патогенеза, диагностики, клиники и лечения возрастной макулярной дегенерации //Офтальмология.- 2009. -Том 6.- № 1.- С.87-93.][4. Ермилов В. В., Трофименко О. В. Старческий локальный амилоидоз заднего отдела глаза.// Тезисы докл. 7 съезда офтальмол. - ч.1. - 2000. - 433 с.][5. V.Ermilov, O. Machonina. The role of retinal pigment epithelium cells in amiloidogenesis of senile local eye amiloidosis with age-related macular degeneration // 23rd European Congress of Pathology. 27 August - 1 September 2011. Helsinki. // Virchow’s Arch (20011)459 (Suppl 1): S1 - S329. P.190][6. Зенков Н.К., Ланкин В.З., Меньщикова Е.Б. Окислительный стресс. - М., 2001. - 315c.][7. Киселева Т.Н., Кравчук Е.А., Лагутина Ю.М. Современные аспекты патогенеза, клиники и медикаментозного лечения неэкссудативных форм возрастной макулярной дегенерации // Клиническая офтальмология. - 2006. - Т. 7. - № 3. - С. 99-102.][8. Barrow CJ, Small DH. Abeta peptide and Alzheimer’s disease: celebrating a century of research. 2007.][9. Gass J.D. Choroidal neovascular membranes their visualization and treatment// Trans.Am.Acad. Ophthal. Otolaryng. - 1973. Vol. 77- P. 310-320.][10. Holz F., Pauleikhoff D., Spaide R.F., Bird A.S. Age-related macular degeneration. Berlin; Heidelberg: Springer-Verlag, 2004. 238 p.][11. Iseri PK, Altinas O, Tokay T, Yuksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol. 2006;26(1)18-24.][12. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer’s Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:11830-11835.][13. Lip P. L., Blann A. D., Hope-Ross M. et al. Age-related macular degeneration in associated with increased vascular endothelial growth factor, hemoreology and endothelial dysfunction.// Ophthalmol. - 2001. - v.108. - №4. - р.705 - 710][14. Leon J. Thal at al. The Role of Biomarkers in Clinical Trials for Alzheimer Disease, 2006. PMS][15. Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest. 2006;116:378-385.][16. Ning A, Cui J, To E, Ashe KH, Matsubara J. 2008; Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci.;49(11):5136-5143.][17. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F. Morphological and functional retinal impairment in Alzheimer’s disease patients. Clin Neurophysiol. 2001;112(10)1860-1867.][18. Parnell M, Guo L, Abdi M, Cordeiro MF. Ocular manifestations of Alzheimer's disease in animal models. 2012; Int J Alzheimers Dis. 2012:786494.][19. Yoshida T, et al. (2005) The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J Clin Invest 115:2793-2800.][20. Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC. Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? 2012;34(3):633-49.]